Tivicay® (dolutegravir) 50-mg tablets for HIV-1
FDA has approved Viiv Healthcare’s integrase inhibitor Tivicay® (dolutegravir) 50-mg tablets, for use with other antiretroviral agents in treating HIV-1 infection....3908 days ago
3406 days ago
Illumina to Acquire Pacific Biosciences for Approximately $1.2 Billion !
...t for Illumina to acquire Pacific Biosciences at a price of $8.00 per Pacific Biosciences share in an all-cash transaction.The agreement has been approved by the board of directors of...2004 days ago